Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM). - Université de Lille
Article Dans Une Revue Swiss Medical Weekly Année : 2021

Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM).

S. Hofer
  • Fonction : Auteur
K. Keller
  • Fonction : Auteur
L. Imbach
  • Fonction : Auteur
U. Roelcke
  • Fonction : Auteur
G. Hutter
  • Fonction : Auteur
H. Thomas
  • Fonction : Auteur
C. Hertler
  • Fonction : Auteur
F. Vasella
  • Fonction : Auteur
D. Cordier
  • Fonction : Auteur
M. Neidert
  • Fonction : Auteur
A. Hottinger
  • Fonction : Auteur
D. Migliorini
  • Fonction : Auteur
T. Pflugshaupt
  • Fonction : Auteur
N. Eggenberger
  • Fonction : Auteur
B. Baumert
  • Fonction : Auteur
H. Läubli
  • Fonction : Auteur
D. Gramatzki
  • Fonction : Auteur
M. Reinert
  • Fonction : Auteur
G. Pesce
  • Fonction : Auteur
P. Schucht
  • Fonction : Auteur
I. Frank
  • Fonction : Auteur
D. Lehnick
  • Fonction : Auteur
T. Weiss
  • Fonction : Auteur
W. Hans-Georg
  • Fonction : Auteur
F. Wolpert
  • Fonction : Auteur
P. Roth
  • Fonction : Auteur
M. Weller
  • Fonction : Auteur

Résumé

OBJECTIVE:The management of brain tumour patientswho would like to resume driving is complex, and needsmultidisciplinary input and a consensus among treatingphysicians. The Swiss Neuro-Oncology Society (Swiss-NOS) and the Swiss Society for Legal Medicine (SGRM)aim to provide guidance on how to assess “fitness-to-dri-ve” of glioblastoma patients and to harmonise the relevantprocedures in Switzerland.METHODS:At several meetings, Swiss neuro-oncologistsdiscussed common practices on how to advise patientswith a stable, i.e., non-progressive, glioblastoma, whowish to resume driving after the initial standard tumourtreatment. All participants of the SwissNOS meetings wereinvited twice to return a questionnaire (modified Delphiprocess) on specific tools/procedures they commonly useto assess “fitness-to-drive” of their patients. Answers wereanalysed to formulate a tentative consensus for a struc-tured and reasonable approach.RESULTS:Consensus on minimum requirements for a“fitness-to-drive”programme for glioblastoma patientscould be reached among Swiss neuro-oncologists. Therecommendations were based on existing guidelines andexpert opinions regarding patients with seizures, visualdisturbances, cognitive impairment or focal deficits forsafe driving. At this point in time, the Swiss neuro-oncol-ogists agreed on the following requirements for glioblas-toma patients after the initial standard therapy and withouta seizure for at least 12 months: (1) stable cranial mag-netic resonance imaging (MRI) according to ResponseAssessment in Neuro-Oncology (RANO) criteria, to berepeated every 3 months; (2) thorough medical history, in-cluding current or new medication, a comprehensive neu-rological examination at baseline (T0) and every 3 monthsthereafter, optionally an electrocencephalogram (EEG) atbaseline; (3) ophthalmological examination including visu-al acuity and intact visual fields; and (4) optional neuropsy-chological assessment with a focus on safe driving. Testresults have to be compatible with safe driving at any time-point. Patients should be informed about test results andoptionally sign a document.CONCLUSIONS:We propose regular thorough clinicalneurological examination and brain MRI, optional EEG,neuropsychological and visual assessments to confirm “fit-ness-to-drive” for glioblastoma patients after initial tumour-directed therapy. The proposed “fitness-to-drive” assess-ments for glioblastoma patients serves as the basis for a prospective Swiss Pilot Project GLIODRIVE (BASEC Pro-jectID 2020-00365) to test feasibility, adherence and safe-ty in a structured manner for patients who wish to resumedriving. Research will focus on confirming the usefulnessof the proposed tools in predicting “fitness-to-drive” andmatch results with events obtained from the road trafficregistry (Strassenverkehrsamt).
Fichier principal
Vignette du fichier
article.pdf (1.3 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04429480 , version 1 (31-01-2024)

Licence

Identifiants

Citer

S. Hofer, K. Keller, L. Imbach, U. Roelcke, G. Hutter, et al.. Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM).. Swiss Medical Weekly, 2021, Swiss Medical Weekly, 151, pp.w20501. ⟨10.4414/smw.2021.20501⟩. ⟨hal-04429480⟩

Collections

UNIV-LILLE
8 Consultations
0 Téléchargements

Altmetric

Partager

More